These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pediatric neurocysticercosis: current challenges and future prospects. Singhi P; Saini AG Pediatric Health Med Ther; 2016; 7():5-16. PubMed ID: 29388588 [TBL] [Abstract][Full Text] [Related]
4. Pediatric Neurocysticercosis. Singhi P; Saini AG Indian J Pediatr; 2019 Jan; 86(1):76-82. PubMed ID: 28929415 [TBL] [Abstract][Full Text] [Related]
5. Neurocysticercosis: a review of current status and management. Sinha S; Sharma BS J Clin Neurosci; 2009 Jul; 16(7):867-76. PubMed ID: 19394828 [TBL] [Abstract][Full Text] [Related]
6. Neurocysticercosis: the enigmatic disease. Agapejev S Cent Nerv Syst Agents Med Chem; 2011 Dec; 11(4):261-84. PubMed ID: 22300228 [TBL] [Abstract][Full Text] [Related]
7. The many facets of disseminated parenchymal brain cysticercosis: A differential diagnosis with important therapeutic implications. Del Brutto OH; Garcia HH PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009883. PubMed ID: 34793447 [TBL] [Abstract][Full Text] [Related]
8. CystiHuman: A model of human neurocysticercosis. Bonnet G; Pizzitutti F; Gonzales-Gustavson EA; Gabriël S; Pan WK; Garcia HH; Bustos JA; Vilchez P; O'Neal SE; PLoS Comput Biol; 2022 May; 18(5):e1010118. PubMed ID: 35587497 [TBL] [Abstract][Full Text] [Related]
10. Neurocysticercosis: a review on status in India, management, and current therapeutic interventions. Ahmad R; Khan T; Ahmad B; Misra A; Balapure AK Parasitol Res; 2017 Jan; 116(1):21-33. PubMed ID: 27774576 [TBL] [Abstract][Full Text] [Related]
12. Neurocysticercosis: Diagnostic problems & current therapeutic strategies. Rajshekhar V Indian J Med Res; 2016 Sep; 144(3):319-326. PubMed ID: 28139530 [TBL] [Abstract][Full Text] [Related]
13. [Neurocysticercosis: its aetiopathogenesis, clinical manifestations, diagnosis and treatment]. Alarcón F Rev Neurol; 2006 Oct; 43 Suppl 1():S93-100. PubMed ID: 17061203 [TBL] [Abstract][Full Text] [Related]
14. Current approaches to cysticidal drug therapy for neurocysticercosis. Del Brutto OH Expert Rev Anti Infect Ther; 2020 Aug; 18(8):789-798. PubMed ID: 32331507 [TBL] [Abstract][Full Text] [Related]
17. Assessing the burden and spatial distribution of Taenia solium human neurocysticercosis in Ecuador (2013-2017). Coral-Almeida M; Henriquez-Trujillo AR; Asanza S; Erazo C; Paucar M; Calvopiña M PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008384. PubMed ID: 32511228 [TBL] [Abstract][Full Text] [Related]
18. Active neurocysticercosis, parenchymal and extraparenchymal: a study of 38 patients. Monteiro L; Almeida-Pinto J; Stocker A; Sampaio-Silva M J Neurol; 1993 Nov; 241(1):15-21. PubMed ID: 8138816 [TBL] [Abstract][Full Text] [Related]
19. [Paediatric neurocysticercosis: two case reports]. Frieiro-Dantas C; Serramito-García R; Reyes-Santías RM; Rico-Cotelo M; Allut AG; Gelabert-González M Rev Neurol; 2013 Jan; 56(2):86-90. PubMed ID: 23307354 [TBL] [Abstract][Full Text] [Related]
20. Managing neurocysticercosis: challenges and solutions. Fogang YF; Savadogo AA; Camara M; Toffa DH; Basse A; Sow AD; Ndiaye MM Int J Gen Med; 2015; 8():333-44. PubMed ID: 26527895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]